RETREG1 and cancer: We also observed a similar degradation of FAM134B in U251 glioblastoma cells (Supplementary Fig. 2l) and C32 melanoma cells (Supplementary Fig. 2m) indicating ER-phagy as a general mechanism that cancer cells exploit to counteract hypoxia-induced stress.